Analysis of prognostic factors after 16 years of follow-up in a randomized phase II trial of neoadjuvant FAC compared with CMF in stage III breast cancer.
Julieta Leone
No relevant relationships to disclose
Jose Pablo Leone
No relevant relationships to disclose
Carlos Teodoro Vallejo
No relevant relationships to disclose
Juan Eduardo Perez
No relevant relationships to disclose
Alberto Omar Romero
No relevant relationships to disclose
Mario Raul Machiavelli
No relevant relationships to disclose
Luis Romero Acuna
No relevant relationships to disclose
Maria Ester Dominguez
No relevant relationships to disclose
Mario Langui
No relevant relationships to disclose
Hebe Margot Fasce
No relevant relationships to disclose
Bernardo Amadeo Leone
No relevant relationships to disclose
Eduardo Ortiz
No relevant relationships to disclose
Julian Iturbe
No relevant relationships to disclose
Ariel Osvaldo Zwenger
No relevant relationships to disclose